1. Modelling analysis of intravenous glucose tolerance test glucose and insulin concentrations can provide measures of insulin sensitivity and metabolism from a single straightforward procedure. However, little is known of the effects of blood arterialization on modelderived parameters. 2. Intravenous glucose tolerance tests were carried out on 18 subjects, with measurement of glucose and insulin concentrations in simultaneously sampled nonarterialized and arterialized blood. Blood oxygen saturation, partial pressure of COz and pH were measured on both non-arterialized and arterialized blood during the intravenous glucose tolerance test. Using the minimal models of glucose disappearance and post-hepatic insulin delivery, measures of insulin sensitivity, glucosedependent glucose disposal, firstand second-phase post-hepatic insulin responsiveness to glucose and plasma insulin elimination rate were derived from intravenous glucose tolerance test glucose and insulin concentrations in both arterialized and non-arterialized blood. 3. During the intravenous glucose tolerance test mean blood oxygen saturation was 6.7% higher, partial pressure of C02 was 0.3 kPa lower and pH was 0.015 higher in arterialized than non-arterialized blood. Mean parameter values did not differ when derived from measurements made on non-arterialized and arterialized blood. Modelderived parameters were not related to the degree of arterialization, although there was some consistent variation with sampling site for parameters of glucosedependent glucose disposal (S,), first-phase post-hepatic insulin responsiveness (41) and insulin elimination (ni).
INTRODUCTION
In analysing whole body glucose metabolism, measurement of arterial rather than venous glucose concentrations has been preferred, since changes in arterial blood glucose concentrations are the result of glucose metabolism in all tissues of the body, whereas changes in venous blood glucose concentrations will be affected by the particular tissue which is being drained. However, arterial blood sampling is undesirable for techniques that are to be used in relatively large numbers of experimental subjects. Venous blood, obtained by retrograde cannulation of a dorsal hand vein, with the hand kept heated, has been found to be an effective alternative Mathematical modelling analysis of intravenous glucose tolerance test (IVGTT) glucose and insulin concentrations has been widely used to provide measures of glucose and insulin metabolism C4-91, and we have found these models to be highly effective in discriminating significant effects on insulin sensitivity and secretion [ 10-141. Venous blood glucose and insulin measurements have been consistently used with these procedures without standardization for the degree of arterialization of blood on which measurements are made; this might have affected the parameter values obtained, or their variability. Bergman et al. [15] reported the results of a small study which suggested that use of nonarterialized or arterialized blood made little difference to model-derived parameters. However, the groups studied were relatively small (n = 8), tests with and without arterialization were carried out on separate occasions and there was no assessment of the degree of blood arterialization.
In the present study we have carried out simultaneous sampling of non-arterialized and arterialized blood during an IVGTT, in which the endogenous insulin response has been augmented by use of a higher glucose dose (0.5 g/kg compared with 0.3 g/ kg), rather than by injection of tolbutamide or insulin. Blood arterialization has been evaluated by measurement of percentage oxygen saturation, partial pressure of C 0 2 (Pco2) and pH, and skin temperature has been taken throughout the procedure. Parameters of insulin sensitivity and insulin delivery, derived from the minimal models of glucose disappearance [ 161 and post-hepatic delivery [ 171, using glucose and insulin measurements from non-arterialized or arterialized blood, have been compared.
METHODS

Subjects
We studied 18 subjects (14 male, four female) aged between 19 and 53 years. Fourteen were healthy and non-obese (percentage of ideal body weight: 83-1 19%, Metropolitan Life Tables), one was obese (percentage of ideal body weight 153%), two had hyperlipidaemia and one had polycystic ovarian syndrome. The study was approved by the Ethical Committee of the Paddington and North Kensington Health Authority, and written informed consent was obtained from all subjects.
Procedures
Subjects fasted overnight ( > 12 h) before their test. Tests were performed in a metabolic ward and began between 09.00 and 10.00 hours. Subjects remained in a semi-recumbent position throughout their test. An indwelling cannula was inserted into an antecubital vein in each arm, one for glucose administration and the other for sampling of nonarterialized blood. A butterfly cannula, for sampling of arterialized blood, was inserted in a retrograde direction into a dorsal vein of the hand contralateral to the arm from which non-arterialized blood was to be taken. Temperature probes, attached to a multi-channel digital thermometer (Edale Instruments type GC20), were taped to the skin adjacent to each sampling site. Cotton pads were taped over each temperature probe for insulation from external temperature variation. The hand from which arterialized blood was to be taken was placed on a warming pad, and an infra-red heating lamp was placed above the hand.
After 15 min, two successive blood samples (10min apart) were drawn into plastic tubes containing lithium heparin for measurement of fasting plasma glucose and insulin concentrations. Blood samples were also taken into heparinized 2 ml plastic syringes for immediate measurement of oxygen saturation, P C O , and pH. An intravenous glucose injection [OSg of glucose/kg body weight as a 50% (w/v) solution of D-glucose] was given over 3min and non-arterialized and arterialized blood samples were taken at 1, 2, 3, 4, 5, 7, 10, 15, 20, 30, 45, 60, 75, 90, 120, 150 and 180min after the injection. Samples were also taken at 5, 10, 15, 20, 30 , 45, 60, 75, 90, 120, 150 and 180 min for immediate measurement of blood gases and pH. Skin temperature at each sampling site was also recorded at these times.
Four subjects received a modified test to ensure that there was no effect of injection of glucose on arterialized blood glucose concentrations taken from the sampling site on the injection arm. The procedure was as described above except that an additional cannula was inserted retrograde into the hand of the arm from which non-arterialized blood samples were taken, and both hands were subjected to the same degree of heating, with skin temperatures matched as closely as possible. Samples were taken throughout the test from this site as well as from the other two sites.
To provide an estimate of mean oxygen saturation during an IVGTT for which hand heating for arterialization of non-arterialized blood had not been undertaken, oxygen saturation was measured at baseline and at 20, 45, 90, 120, 150 and 180min during 28 IVGTTs not carried out as part of the present study.
Laboratory procedures
Plasma glucose concentration was measured by a glucose oxidase procedure [ 181. Plasma insulin concentration was measured (on samples stored at -20°C) using the radioimmunoassay procedure of Albano et al. [19] . Quality control was monitored at three different levels using commercially available freeze-dried sera and stored, pooled sera. Coeficients of variation were between 2 and 3% (plasma glucose concentration) and 4 and 6% (plasma insulin concentration). Oxygen saturation, PcoZ and pH were measured on a Radiometer ABL2 Acid Base Laboratory, sited in a room adjacent to the day ward where tests were carried out. Quality control was monitored at four different levels using commercially available solutions (Radiometer Qualicheck). Coefficients of variation were between 1.1 and 3.8% (oxygen saturation), 1.7 and 3.2% (Pco2) and 0.06 and 0.10% (pH).
Modelling analyses
The modelling analyses employed in the present study are described in detail in Clinical Science Appendix 92/1, copies of which are available from the Librarian, Royal Society of Medicine, 1 Wimpole Street, London W1M 8AE, U.K. Briefly, the minimal model of glucose disappearance of Bergman et al. [16] provided measures of the sensitivity of glucose elimination to insulin (Si, inversely proportional to insulin resistance) and glucose-dependent glucose elimination (Sg). The equations of the minimal model of glucose disappearance are as follows:
where GI is the plasma glucose concentration at time t, I , is the plasma insulin concentration at time t , XI is the insulin activity in the remote compartment at time t, G b is the basal plasma glucose concentration, I b is the basal plasma insulin con-centration and pl, p 2 , and p 3 are model parameters.
Si is then given by the ratio p 3 / p 2 and S, by pl.
Measures derived from this model have been the subject of validation studies [20- 223. The minimal model of post-hepatic insulin delivery of Toffolo et al. [17] provided measures of the sensitivity of net first-phase post-hepatic insulin delivery to glucose first-phase insulin responsiveness), the sensitivity of second-phase post-hepatic insulin delivery to glucose ( 42, second-phase insulin responsiveness) and the insulin elimination constant (ni =In 2/insulin half-life) [17] . The model is described by the following equations:
dl,/dt=IDR-Z,.n, where I, is the plasma insulin concentration at time [17] . Model identifications were carried out using custom-written software incorporating standard numerical routines [23] . In analyses employing the minimal model of glucose disappearance a mixing phase of 10min was allowed, the basal glucose concentration was taken as the glucose concentration at the end of the IVGTT, and insulin concentrations were taken as the increment above the minimum insulin concentration encountered during the IVGTT. Where possible, identical weighting and constraints were used for the analysis of paired non-arterialized and arterialized blood glucose and insulin concentrations. For modelling analyses to be acceptable, parameter estimates were required to have fractional SDs of less than 100% and to be positive [16] .
IDR =/.?(GI -h). t
Data analyses
All variables were transformed to normalize their distributions, using transforms previously established in larger groups [lo, 121 (see Table 2 ). Statistical analyses were carried out using BMDP Statistical Software (Los Angeles, CA, USA.). Analyses comparing measures from non-arterialized and arterialized blood included Student's paired ttest, linear regression analysis and derivation of Pearson correlation coefficients. The significance of the divergence of regression line slopes from 1, and intercepts from 0, was determined by the calculation of slope and intercept SEMs and the derivation of t values [24] .
RESULTS
Dorsal hand vein glucose concentrations during the first 10min of the IVGTT, in the four subjects who had arterialized blood samples taken from both hands, are shown in Table 1 with the accompanying blood oxygen saturation. Blood oxygen saturation was very similar at both hand sampling sites and there was no evidence of contamination by the injected glucose of blood sampled from the dorsal hand vein.
Mean differences between arterialized and nonarterialized blood in plasma glucose and insulin concentrations, oxygen saturation, P c O 2 and pH and in temperature at the arterialized and nonarterialized blood sampling sites are shown in Fig.  1 . The plasma glucose concentration in arterialized blood was significantly higher than that in nonarterialized blood at 2 min (P ~0 . 0 0 1 ) and at 1, 3, 4, 5 and 7min (P <0.01). The plasma insulin concentration was higher in arterialized blood than in non-arterialized blood at 2 min (P <0.001) and 3min (P<O.O5). Mean oxygen saturation, pH and temperature were higher at each sampling point during the IVGTT in arterialized than in nonarterialized blood, and mean PcoZ was lower. Differences in oxygen saturation, Pco2, pH and temperature at each sampling point were all signifi- Table I cant, with the exception of pH at 75min. Mean blood oxygen saturation during the IVGTT was 92.3% and 85.6%, mean Pcoz was 5.9 and 5.5kPa
and mean pH was 7.409 and 7.394 in arterialized and non-arterialized blood, respectively, and mean skin temperature was 41.1 and 32.6"C at the Sampling sites for arterialized and non-arterialized blood, respectively. The mean oxygen saturation during the 28 IVGTTs carried out without hand heating was 78.1% (range 57.6-89.1%). Individual and mean values for mean oxygen saturation throughout the IVGTT and for modelderived parameters Si, S,, 41, & and n from arterialized and non-arterialized blood are given in Table 2 . Parameters of the post-hepatic insulin delivery model were not obtained in four cases in which, due to cannula obstruction, three or more samples could not be taken at the arterialized blood sampling site during the first 7min of the IVGTT.
There were no significant differences between model-derived parameters determined from plasma glucose and insulin concentrations in arterialized or non-arterialized blood, although there were distinct intra-individual differences between the parameter estimates in some cases. The correlation coefficients between parameters S,, S , and 41 determined from arterialized or non-arterialized blood were 0.84, 0.80 and 0.79 ( P < 0.001), respectively (Table 3) . Correlations for 42 and n were 0.52 and 0.50 (P<O.O5).
These weaker correlations were associated with some particularly marked discrepancies between paired values of $ J~ and n (e.g. subject nos. 6-8). The regression line slopes for arterialized and nonarterialized estimates of 41 and n differed significantly from 1 and the intercepts for S, and 41 differed significantly from 0.
No significant correlations were found between model-derived parameters and blood oxygen saturation. Neither did the difference between modelderived parameters derived from arterialized and non-arterialized blood correlate with the difference in blood oxygen saturation (correlation coefficients ranged between -0.16 and 0.15, and regression line slopes between -0.02 and 0.01).
DISCUSS10 N
Analyses using the minimal model of glucose disappearance utilize glucose and insulin concentrations from 10min after the start of the IVGTT. Thus the similarity in mean glucose disappearance model parameters derived from measurements made on arterialized and non-arterialized blood is consistent with the limited differences observed in mean glucose and insulin concentrations. Analyses employing the post-hepatic insulin delivery model proceed from the peak insulin concentration achieved during the first 10min of the IVGTT. On average, this occurs at 4min, so again little difference would be expected between parameters of the post-hepatic insulin delivery model measured in arterialized and non-arterialized blood. There was, however, evidence from the regression analyses for some consistent variation between arterialized and non-arterialized estimates of S,, 41 and n,. Since these variables showed no relationship to the degree of blood oxygen saturation, it must be concluded that sampling site per se was introducing some variation. The parameters S , and ni quantify elimination rates for glucose and insulin, independent of other measures, and the parameter $1 is also partly determined by the insulin elimination rate [17] . Such rates of elimination are likely to vary with the muscle mass being drained, so local variations in estimates of these parameters may be expected. In contrast, the insulin sensitivity parameter, s,, and second-phase post-hepatic insulin responsiveness, 42, are determined by relative changes in glucose and insulin concentrations, one to the other, and may, therefore, be less susceptible to consistent variation according to sampling site. In addition to these consistent variations, there was, in some cases, intra-inividual variation in para- arterialized and arterialized blood in our study was apparently less than might have been achieved, since there was relatively high oxygen saturation in the non-arterialized blood samples. A value of 85.6% was obtained, in contrast to the oxygen saturation of 78.1% found in non-arterialized blood when no heating was undertaken. The mean saturation in arterialized blood (92.3%) was similar to that reported by others [26] . The high non-arterialized blood oxygen saturation in our study is likely to be a consequence of heating the contralateral hand. Use of a heating blanket results in an increase in core temperature and increased blood flow [27, 281, and there is also likely to be reflex vasodilatation independent of this increase in temperature [3, 291. All these effects would act to increase venous blood oxygen saturation and reduce the difference between non-arterialized and arterialized blood oxygen saturation. This is a potential problem for arteriovenous difference studies, although in the present study the increase in blood flow may have acted to minimize variations in glucose and insulin clearance. Use of a warm-air box rather than a heating blanket and infra-red lamp might have increased the oxygen saturation differential [28], although nonarterialized blood oxygen saturation would probably still have been elevated above the level obtained without heating of the contralateral hand [3] . To maximize the oxygen saturation differential, it would have been necessary to carry out two IVGTTs, one with hand heating and sampling of arterialized blood, and one without heating and with sampling of non-arterialized blood. This would, however, have introduced a further element of intraindividual variability into the comparisons of model-derived parameters. There was, nevertheless, a considerable range of mean blood oxygen saturations in our study (75.8-95.6%) and yet there was no evidence of any relationship between degree of oxygen saturation and values for model-derived parameters.
In evaluating insulin sensitivity, arterialized blood glucose and insulin measurements have been adopted for the various glycaemic clamp techniques. During the steady-state established in a glycaemic clamp there are sound theoretical reasons for favouring sampling of arterialized rather than nonarterialized blood. Hyperinsulinaemia, in a glycaemic clamp procedure, is induced by a constant insulin infusion and basal glucose concentrations are held steady by adjusting the rate of a variable glucose infusion until a steady-state is achieved. At steady-state the rate of glucose infusion equals the rate of glucose elimination and this rate, relative to the insulin concentration, provides a measure of the sensitivity of glucose elimination to insulin. In the original description of the glycaemic clamp, the steady-state glucose concentration was established using arterial blood glucose measurements [30]. If venous blood glucose measurements had been made, constant basal venous blood glucose concentrations would have been maintained, but variation between individuals in elimination of glucose by muscle would have resulted in tissues being exposed to non-basal arterial blood glucose concentrations.
In contrast to the steady-state relationships that are evaluated in the glycaemic clamp, glucose and insulin concentrations during the IVGTT are changing continuously, and the modelling analysis enables measurement of the constants that determine the relationship between these changing concentrations. Our results suggest that there is no overriding reason for favouring arterialized over nonarterialized blood measurements, and this might relate to evaluation of the relationship between changes in concentration in modelling analysis, rather than steady-state concentrations. It could be argued that arterial blood glucose concentrations more accurately reflect the stimulus to pancreatic insulin secretion, whereas changes in nonarterialized blood glucose concentrations more accurately reflect the effect of insulin at the principal sites of insulin-stimulated glucose uptake. However, in the absence of measurements of insulin concentration and glucose elimination at the actual sites of insulin-stimulated glucose uptake, an approximation must be made which may be provided either by non-arterialized or arterialized blood concentrations. We have found no differences between mean model-derived parameters of glucose and insulin metabolism derived from either non-arterialized or arterialized blood, so sampling of non-arterialized blood at the more convenient and reliable antecubital vein sampling site would appear to be the procedure of choice. Nevertheless, in multiple studies, care should be taken to standardize the sampling site if optimum precision is to be ensured.
